Healthcare & Life Sciences
Egetis Therapeutics
Swedenwww.egetis.com/
Egetis Therapeutics is a Healthcare & Life Sciences startup based in Sweden, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Egetis Therapeutics
Egetis Therapeutics is a company headquartered in Sweden. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Egetis Therapeutics is a pharmaceutical company developing treatments for rare diseases, including Emcitate (tiratricol) for MCT8 deficiency, which has EMA approval, and Aladote (calmangafodipir) for acetaminophen overdose.
Explore Egetis Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.